- Nachrichtendetail
-
21.05.2024 14:04:20 - dpa-AFX: *LILLY'S MIRIKIZUMAB SHOWS POSITIVE RESULTS: OVER HALF OF CROHN'S PATIENTS ACHIEVE REMISSION, EVEN AFTER BIOLOGIC FAILURE
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Eli Lilly & Co | 858560 | NYSE | 879,730 | 20.06.24 20:01:28 | -11,730 | -1,32% | 879,100 | 879,880 | 893,000 | 891,460 |
